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Summary 
The assembly of the classical, polymorphic major histocompatibility complex class I molecules 
in the endoplasmic  reticulum requires  the presence of peptide ligands  and ~2-microglobulin 
(~2m). Formation of this trimolecular complex is a prerequisite  for e~cient transport to the 
cell surface, where presented peptides are scanned by T lymphocytes. The function of the other 
class I molecules is in dispute.  The human, nonclassical class I gene, HLA-E, was found to be 
ubiquitously transcribed, whereas cell surface expression was dif~cult to detect upon transfection. 
Pulse chase experiments  revealed that the HLA-E heavy chain in transfectants,  obtained with 
the  murine  myeloma cell  line  P3X63-Ag8.653  (X63),  displays a  significant  reduction  in 
oligosaccharide maturation and intracellular transport compared with HLA-B27 in corresponding 
transfectants. The accordingly low HLA-E cell surface expression could be significantly enhanced 
by either reducing the culture temperature or by supplementing the medium with human ~2m, 
suggesting inefficient binding of endogenous peptides to HLA-E. To analyze whether HLA-E 
binds peptides and to identify the corresponding ligands, fractions of acid-extracted material from 
HLA-E/X63 transfectants were separated by reverse phase HPLC and were tested for their ability 
to enhance HLA-E cell surface expression. Two fractions  specifically increased the HLA class 
I expression on the HLA-E transfectant  clone. 
A  variety of the molecules involved in vertebrate immune 
recognition are encoded by the MHC. In humans these 
include three highly polymorphic dass I transplantation  an- 
tigens (HLA-A, -B, -C). These so-called dassical class I MHC 
molecules are composed of a MHC-encoded transmembrane 
heavy chain (Mr ~44,000;  44K)  noncovalently associated 
with ~2-microglobulin (Bzm).  1 They present  antigens  to 
CTL, due to their capacity to bind peptides from intracellu- 
larly degraded proteins, and expose them on the cell surface 
(1, 2). Moreover, intracellular  transport and cell surface ex- 
pression of classical class I molecules are controlled by the 
efticient assembly of this trimolecular complex and depend 
on the availability of high affinity peptides within the en- 
doplasmic reticulum (3-9). Whether or not the less poly- 
morphic nonclassical class I loci (HLA-E  [10, 11], -F [12], 
and -G  [13, 14]) also function in antigen presentation  in 
humans is unknown. 
Like the classical HLA class I genes, HLA-E, localized be- 
1 Abbreviations used in this~t~r: BFA, brefeldin A; ~zm, ~2-microglobulin; 
hu~zm, human ~2-microglobulin; endo H, endoglycosidase H. 
tween the HLA-C and the HLA-A loci, is highly transcribed 
in most tissues (10, 11,  15; M. Ulbrecht, manuscript sub- 
mitred for publication). Conflicting results have been obtained 
concerning the cell surface expression of the HLA-E-encoded 
class I heavy chain.  Upon transfection  of a HLA-E 6.2-kb 
HindlII subclone of cosmid B1.1 (E'0102) into an HLA dass 
I-negative mutant B-LCL, only an intracellular 41 K heavy 
chain could be coprecipitated  with human ~2m  (hu~zm) 
(10,  16). In constrast,  the transfer of a 16-kb EcoRI sub- 
clone derived from cosmid RS5 was reported to result in 
a detectable  cell surface expression  when transfected  into 
mouse L cells, which also express hu~2m (17). We recently 
found low cell surface expression of HLA-E antigen in the 
mouse myeloma cell line P3X63-AgS.653  (X63) transfected 
with cosmid cd3.14 (E*0105) and hu~/2m. The discrepancy 
between the size of the metabolically labeled HLA-E heavy 
chain (Mr 41 K) and the size of the iodinated surface HLA-E 
chain (Mr 42 K) precipitated from these cells suggests a de- 
fect in N-linked glycan maturation. Here we present evidence 
that the lack of productive cell surface expression of HLA-E 
is the result of a low stability of the HLA-E molecule during 
transport and on the cell surface, which may be due to its 
defective binding of available endogenous peptides. 
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Cell Culture.  P3X63-Ag8.653  (X63) transfected with either 
human Bzm, human Ban and  HLA-E, or human Ban and HLA- 
B27, as described (M. Ulbrecht, manuscript submitted for publi- 
cation),  was  maintained  in  RPMI  1640  (10%  FCS,  1%  peni- 
cillin/streptomycin;  all from Gibco Laboratories, Grand Island, NY) 
at 37~  in 6%  CO2. 
10  s cells per microtiter plate well were kept for 12 h in 200 #1 
of RPMI 1640 at either 37, 26, or 37~  in the presence of 12/zg/ml 
purified human Ban (Sigma Chemical Co., St. Louis,  MO). 
2  x  10  s cells per microtiter plate well were preincubated for 
30 rain at 37~  in 200/~1  of RPMI  1640 containing 10/~g/ml 
brefeldin A (Sigma Chemical Co.). Cells were then kept for 5 h 
either at 37~  with or without the addition of 12/~g/ml of purified 
human Ban, or at 26~ 
Fractions of reverse phase HPLC-separated acid-extracted mate- 
rial were dissolved in RPMI 1640. One-half of each fraction was 
added  to  1.5  x  10  s  cells  of either  X63/HLA-E,  huBan,  or 
X63/HLA-B27, huBan transfectants. Incubation was performed 
for 7 h at 37~  in microtiter plate wells in a total volume of 200 
#1 of RPMI  1640. 
Antibodies.  Supernatants of hybridomas producing mAbs specific 
for human  class  I,  B9.12.1  (IgG2a [18]);  human  B2m, BBM.1 
(IgG2b;  American  Type Culture  Collection,  Rockville,  MD); 
purified mAbs  specific for human  CD4,  M-T151 (IgG2a),  and 
M-T242 (IgG2b); and human class I heavy chain, A1.4 (IgG2b [19]; 
United  Biomedical  Inc.,  Hauppauge,  NY)  were  used  for im- 
munofluorescence and immunoprecipitation. 
Immunofluorescence Staining and FACS  |  Analysis.  1-2  x  10  s 
cells per microtiter plate well were washed twice with ice-cold PBS, 
then incubated with 40/zl of BBM.1 or B9.12.1 hybridoma super- 
natant or 40 #1 of A1.4 at a concentration of 20/~g/ml for 30 min 
on ice. Calls were washed thrice with PBS and then incubated with 
40/~1 dichlorotriazinyl aminofluorescein (DTAF)-conjugated goat 
anti-mouse Ig-specific antiserum (Dianova) at a concentration of 
25 #g/ml for 30 min on ice. After four washes with PBS, samples 
were fixed with 1% paraformaldehyde in PBS and analyzed on a 
FACScan |  flow cytometer (Becton Dickinson & Co., Mountain 
View, CA). 5,000 viable cells were measured. Mean fluorescence 
was obtained with logarithmic amplification of fluorescence inten- 
sity expressed in channels,  where 4 logs span 1,024 channds (256 
channels per log).  An  increase  in fluorescence  intensity of 160 
channels represents a 4.2-fold increase in expression, and 120 channels 
represent a threefold increase. 
Preparation of Radiotabeled Proteins.  For metabolic labeling, cells 
(1-3  x  106/ml) were preincubated for 1.5 h in methionine-free 
MEM  supplemented  with  10%  dialyzed FCS  (all  from Gibco 
Laboratories) at 37~  Cells were then pulse labeled with 20 #Ci/ml 
[3SS]methionine (>1,000 Ci/mmol; Amersham Corp., Arlington 
Heights, IL) for 10 min at 37~  and chased in the presence of a 
200-400-fold molar excess of cold methionine at 37~  or where 
indicated at 26~  At the time points indicated aliquots were re- 
moved and lysed. 
Iodination of cell surface molecules was carried out using the 
lactoperoxidase-glucose  oxidase method (20). In brief, 107 cells cul- 
tured at either 37 or 26~  for 24 h were washed twice with PBS 
and labeled in I ml of PBS with 5 U lactoperoxidase (L-0515; Sigma 
Chemical Co.), 6 U glucose oxidase type V (Sigma Chemical Co.), 
and 1 mCi of carrier-free NanSI (17.4 Ci/mg; DuPont Co., Wil- 
mington, DE) in the presence of  0.01 mM KI and 5 mM D-glucose 
for 20 min at room temperature. Cells were washed five times in 
PBS/10% FCS and lysed. 
ImraunoFrecit~itation  and SDS-PAGE.  [3sS]-Methionine metabol- 
ically labded calls were lysed at 4~  for 30 rain in 0.6 ml lysis 
buffer (1% [wt/vol] NP-40, 2 mM benzamidine HC1, 2 mM PMSF, 
2% [vol/vol] aprotinin in PBS). After sedimentation of nuclei and 
debris  at 15,000 g for 15 rain at 4~  lysates were supplemented 
with 50 #1 of FCS and precleared  at 4~  one to three times for 
12 h with 100 #1 horse serum-saturated Sepharose 6B (Pharmacia 
Fine Chemicals,  Piscataway, NJ), one to two times for 2 h with 
50 #1 of protein A-Sepharose Cb4B (Sigma Chemical Co.), and 
once  for  1  h  with  20  /zl  of isotype control  mAb(M-T151  or 
M-T242)-protein A-Sepharose. After a last preclearing step with 
20 #1 of protein A-Sepharose for 1 h, lysates were incubated for 
1  h  at  4~  with  20  #1  of either  A1.4-  or  B9.12.1-protein 
A-Sepharose.  Immunoadsorbents were washed six times in PBS 
containing 0.2%  (wt/vol) NP-40, resuspended in 50 #1 of SDS 
sample buffer (4.2% SDS, 0.1% 2-ME, 18% glycerol), boiled for 
3 min, and analysed by SDS-PAGE on 9,  10, or 12% gels. The 
gels  were treated with Amplify (Amersham Corp.),  dried, and 
fluorographed at  -85~ 
For 12SI-labeled proteins a  modification of this protocol was 
adopted. After preclearing at 4~  for the first  15 h with 100/~1 
of horse serum-saturated Sepharose and then for 2 h with 25/~1 
of protein A-Sepharose, lysates were sequentially immunoprecipi- 
tated (1 h at 4~  using the following reagents: 20/~1 isotype con- 
trol  M-T151-protein  A-Sepharose,  20  /~l  of  B9.12.1-protein 
A-Sepharose, 20/zl of isotype control M-T242-protein A-Sepharose, 
30  #1  of  A1.4-protein  A-Sepharose,  and  finally  20  #1  of 
BBM.1-protein A-Sepharose.  Between each  round tysates  were 
cleared with 20/~1 of protein A-Sepharose for 2 h at 4~  Further 
treatment of immunoadsorbents was as described.  For analysis, 10 
or 12%  SDS-PAGE was used. 
Endo H Treatment of Radiolabeled Proteins.  After washing with 
PBS containing 0.2%  (wt/vol) NP-40, immunoadsorbents were 
split into two equal aliquots, resuspended in 26/~1 of sodium phos- 
phate buffer (50 mM, pH 5.5) supplemented with 0.1 M  2-ME 
and 0.02% SDS, boiled for 1 min, and then cooled on ice. 1/~1 
of 200 mM PMSF and 8 #1 ofendo H (1 mU//~l; Boehringer Mann- 
helm Biochemicals) were added (control samples receiving 8/~1PBS), 
and digestion was performed at 37~  for 15 h under gentle agita- 
tion. Samples were analyzed as described by 10 or 12% SDS-PAGE. 
Acid  Extraction of Peptides and HPI_s  Separation.  3  x  10  s 
human  B2m/HLA-E-transfected  X63  cells  kept  at  37~  and 
washed twice with PBS were resuspended in 0.1% (vol/vol) TFA. 
Extraction was performed as described (21). Lyophilized material 
was resuspended in 0.1% TFA and subjected to a Sephadex G-25 
gel filtration column (Pharmacia Fine Chemicals). Material of M, 
<10 K was collected and dried by vacuum centrifugation. The ex- 
tract was dissolved in 0.1% TFA and separated  by HPLC (LKB 
Instruments)  on  a  reverse  phase  column,  Hibar  LiChrospher 
(Merck), using (a) 0.1% TFA/H20, and (b) 0.1% TFA/acetoni- 
trile as a solvent system. A linear gradient from 0 to 70% (vol/vol) 
of b in a was applied over a period of 60 min at room temperature. 
The flow rate was adjusted to 1 ml/min. The effluent was moni- 
tored at 206 nm. Fractions of 1 rain were collected and dried by 
vacuum centrifugation. 
Results 
Impaired Intracellular Transport of HLA-E Molecules.  Post- 
translational  modifications  and  intracellular  transport  of 
HLA-E and HLA-B27 heavy chains were investigated by pulse 
chase experiments  (Fig.  1).  Comparing  X63  transfectants, 
expressing only hu~2m,  HLA-E and hu~zm,  or HLA-B27 
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HLA-E dass I heavy  chain. (a) X63 transfectant clones 
expressing either hu~zm (lanes I-3), HLA-E  and hu/3zm 
(lanes 4-7), or HLA-B27  and huB2m (lanes 8-11) were 
metabolically  labeled  for 10 rain and chased  for the times 
indicated at 37"C. HLA dass I molecules  were  iramuno- 
precipitated with mAb A1.4 specific  for HLA class I and 
separated  by 10% SDS-PAGE.  A short exposure  is shown 
to visualize  the process  of  glycan  modification  of  the HLA- 
B27-encoded c~ chain. (b) X63 transfectant clones ex- 
pressing either HLA-E  and hu~zm (lanes 1-4), HLA-B27 
and huBzm (lanes 5-8), or hu/~2m (lanes 9-12) were 
metabolically  labeled  for 10 rain and chased  for the times 
indicated at 37"C. For each time point equal aliquots of 
anti-HLA class I immunoprecipitates with mAb B9.12.1 
were either endo H (+) or mock (-) digested and ana- 
lyzed by 10% SDS-PAGE. 
and hu/32m,  revealed  that  the HLA-B27 molecules showed 
extensive glycan modification during the chase period of 90 
min  (Fig.  1 a)  and expressed predominantly  mature  (endo 
H-resistant) glycans at 120 rain (Fig. 1 b). In contrast, HLA-E 
molecules did not increase in  size  (Fig.  1 a)  and remained 
endo H  sensitive (Fig.  1 b). In biosynthetically labeled cells, 
both HLA-E and HLA-B27 heavy chains were precipitated 
at least partially complexed with B2m (see Fig. 5), irrespec- 
tive of the mAb used (B9.12.1  [18] or A1.4, which also recog- 
nizes denatured  class  I  heavy chains  [19]). 
Enhancement of  HLA-E Surface Expression at Low Tempera- 
ture.  A defect in carbohydrate side chain processing and in- 
tracellular trafficking  of dassical MHC class I molecules, which 
has been observed in the absence of peptide ligands,  could 
be compensated for by a reduction in temperature  (4,  22). 
Culturing the X63 transfectants at 26~  resulted in a three- 
to eightfold increase of human class I-specific cell surface im- 
munofluorescence of the HLA-E transfectant,  whereas no effect 
was observed on the HLA-B27 expression (Fig. 2). Maximum 
expression was reached after a 4-h culture period and per- 
sisted up to 48 h.  Labeling of cell surface class I molecules 
and immunoprecipitation  confirmed the increase of HLA-E 
molecules on the cell surface (Fig. 3). Whereas in metaboli- 
cally labeled cells a M, 41 K  HLA-E heavy chain remained 
endo H  sensitive,  HLA-E antigen expressed on the cell sur- 
face at either 37 or 26~  was endo H  resistant.  A polypep- 
tide  of M,  37  K  coprecipitated  with  cell  surface  HLA-E 
polypeptides and with HLA-B27 heavy chains not complexed 
with 32m.  The origin of this protein is not clear.  It might 
represent  a proteolytically shortened class I  heavy chain  or 
another,  possibly  irrelevant  molecule  coprecipitated  with 
human  class  I  polypeptides. 
Enhancement of HLA-E  Surface Expression by Exogenous 
hu3em.  Sequential  immunoprecipitation  using mAb B9.12.1 
followed by A1.4 indicates that the majority of HLA-E and 
a substantial fraction of HLA-B27 are present on the cell sur- 
face of the X63 transfectants as free class I heavy chains, not 
complexed with/32m (Fig.  3 b). Some HLA-E molecules are 
complexed with 32m on the cell surface when immunopre- 
cipitated with anti-/32m  (BBM.1; Fig. 3 b). Since immuno- 
precipitation  of metabolically and cell surface-labeled cells 
was performed under the same conditions with concentrated 
cell lysates,  the  great  reduction  of B2m-associated HLA-E 
polypeptide in cell surface-labeled lysates should not be due 
to a subsequent enhanced dissociation of the iodinated HLA-E 
molecule  (23). 
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Figure 2.  Enhancement of cell surface ex- 
pression of the HLA-E class I molecules at low 
temperature  or  by  excess huB2m  in  the 
medium. X63 transfectant clones expressing ei- 
ther  hu~zm alone,  HLA-E  and hu~2m,  or 
HLA-B27 and huB2m were cultured either at 
37~  in absence or presence of huBzm, or at 
26~  for 12 h and subsequently stained with 
mAbs  against  HLA  class  I  (B9.12.1)  and 
huB2m (BBM.1). Specific  indirect fluorescence 
profiles were  compared  to  second  antibody 
alone (  ...... ). The same staining profiles were 
obtained using the mAb A1.4. 
Exogenous 32m  has  been shown to stabilize free heavy 
chains on the cell surface (24). Incubation of the X63 trans- 
fectants  for  12  h  at  37~  in  the  presence  of exogenous 
huB2m led to the same increase in HLA-E cell surface ex- 
pression as observed after 12 h at 26~  (Fig. 2). No increase 
was detected  after  a  1-h  incubation  with  hu32m.  An  in- 
creased  level  of huB2m  at  the  cell  surface  of the  HLA-E 
transfectant  was  only  observed when  hu32m  was  in  the 
medium. Again, neither treatment affected HLA-B27 cell sur- 
face expression.  The association of exogenous hu~2m with 
mouse cells has been described to be rapid (24), reaching satu- 
ration after 15 min and reflecting the presence of a large pool 
of free class I heavy chains on the mouse cells  tested.  The 
prolonged time required for enhanced HLA-E expression sug- 
gests that free HLA-E is not present on the cell surface in 
a conformation undetectable by the reagents used, but that 
HLA-E polypeptides reaching  the cell surface are continu- 
ously stabilized. This is confirmed by the lack of any increase 
of HLA-E cell surface expression in the presence of brefeldin 
A (BFA), which inhibits further intracellular transport (Fig. 
4) (4, 25). In contrast, purified mouse 132m did not enhance 
HLA-E cell surface expression (data not  shown). 
Low Temperature Stabilizes Mature HLA-E Molecules.  To 
correlate the enhancement  of HLA-E surface expression at 
low temperature with the underlying processes of intracel- 
lular transport, transfectants were pulse labded at 37~  and 
equal aliquots chased at either 37 or 26~  Low temperature 
reduces  the  turnover  both  of immature  M, 41  K  HLA-E 
heavy chains and HLA-E molecules of M, 42 K  with  ma- 
ture  glycans,  though  the  effect  on  the  processed  form 
predominates (Fig.  5). The mature Mr 42 K form of HLA-E 
is abundantly detectable when chased at 26~  whereas only 
trace amounts precipitate after a 4-h chase at 37~  This is 
not  a result  of an  increase in processing rate,  since equal 
amounts of immature HLA-E c~ chains are precipitated after 
a 4-h chase at both temperatures.  In contrast,  reduction of 
the chase temperature  had little influence on the turnover 
and the oligosaccharide maturation  of the HLA-B27 heavy 
chain. That the residual immature form can be detected after 
4 h at 37~  whereas only a mature product is seen in cells 
chased at 26~  might indicate that HLA-B27-1inked glycan 
modification was accelerated at 26~  At either chase tem- 
perature  the  HLA-E  molecules  failed  to  show  complete 
oligosaccharide maturation even after 8 h, implying a reduced 
rate of intracellular transport.  The experiments suggest that 
after reaching the cell surface at 37~  the mature form may 
dissociate  from Bzm and be rapidly degraded. Since the mAb 
A1.4 also recognizes denatured HLA class I heavy chains,  the 
turnover of the HLA-E polypeptide at 37~  should not be 
due to irreversible denaturation.  Incubation at 26~  or the 
presence of exogenous hu~2m stabilizes  the conformation of 
HLA-E and thus inhibits its degradation. 
Enhancement of  HLA-E Cell Su~ace Expression by Fluted Pep 
tide Material.  The observation that  cell surface expression 
of the HLA-E antigen was only detected upon transfection 
into X63 cells might indicate that these cells contain a low 
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Figure 4.  BFA inhibits enhancement  of cell surface expression of the 
HLA-E class I molecules at low temperature  or by excess hu/Szm in the 
medium. Aliquots of hu/3zm  +,  hu/3~n/HLA-E  +,  hu/3zm/HLA-B27 + 
X63 transfectant clones were preincubated for 30 min at 370C in the pres- 
ence of BFA. Cells were then kept for 5 h either at 370C, with or without 
addition of 12 t~g/ml of purified hu/$2m, or at 260C.  Cells were then 
stained with mAb AL4 by indirect immunolluorescence. Fluorescence in- 
tensities are indicated as mean channels. 
Figure 3.  Increase of mature,  endo H-resistant surface HLA-E mole- 
cules at low temperature.  X63 cells expressing huBzm (a, lanes 5 and 6; 
b, lanes 2 and 7), HLA-B27/hu132m  (a, lanes 7 and 8; b, lanes I, 5, 6, 
and 12), or HLA-E/hu~zm (a, lanes  I-4; b, hnes 3, 4, 8-11, and 13) were 
kept for 24 h at 26 or 370C, as indicated, before surface-labeling  by iodina- 
tion and lysis. Lysates were sequentially immunoprecipitated  with mAbs 
B9.12.1 (a, lanes 1-8; b, lanes 12 and 13), A1.4 (a, lanes 5-11),  and BBM.1 
(b, lanes I-4). Equal aliquots of B9.12.1 (a) and A1.4 immune complexes 
(b) were either endo H (+) or mock (-) digested. Analysis was performed 
by SDS-PAGE on 10%  (a) and 12%  (b) gels. 
amount of sdf-peptides capable of binding to this dass I mol- 
ecule, or that they are permissive to the cell surface transport 
of empty,  otherwise retained,  class  I molecules.  To analyze 
whether HLA-E has the ability to bind peptides and to iden- 
tify  the  corresponding  ligands,  acid  extracts  of  the 
X63/hu/32m,  HLA-E transfectant were prepared as described, 
and peptides  of Mr <10  K  were further fractionated by re- 
verse phase HPLC (21, 26). We reasoned that the small amount 
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Figure 5.  Posttranslational modifications of HLA-E o~ chains induced 
at low temperature. HLA-B27/hu~zm  + (lanes I-6) or HLA-E/hu~zm  + 
(lanes 7-12) X63 transfectants were cultured and metabolically labeled for 
10 min at 37~  Equal aliquots were chased for the times indicated at 
either 37 or 26~  and lysed. HLA class I molecules were immunoprecipi- 
tared with mAb B9.12.1 (lanes 2-6 and 8-I2) and analyzed by 9% SDS- 
PAGE. Representative unspecific immunoprecipitates obtained with iso- 
type control M-TI51 during preclearing are shown for the 0-rain time 
points (lanes I and 7). The upper bands in the HLA class I immunoprecipi- 
tares were endo H  resistant (data not shown) and represent the mature 
form of the class I heavy chains. Trace amounts of mature HLA-E mole- 
cules after a 240-min  chase at 37~  are indicated ( ,91  ). A short exposure 
visualizes oligosaccharide maturation of the HLA-B27 moleafles.  ( <1  ) 
Small amounts of immature HLA-B27 molecules present after a 240-min 
chase  at  370C.  To  demonstrate  coprecipitating  Bzm, remaining im- 
munoprecipitates were analyzed by 12% SDS-PAGE  (bottom). Due to the 
pipetting scheme, the O-min time points contained fewer cells. tll    ~  I  II  ill 
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Figure 6.  Enhancement of HLA-E cell surface  expression by eluted peptide 
material.  X63  transfectants  expressing either  hu~zm  and  HLA-E,  or 
huB2m and HLA-B27, were incubated for 7 h at 37~  with 50% of the 
reverse phase HPLC-separated fractions of acid extracts from X63/HLA-E, 
huB2m transfectants,  and tested for the cell surface expression  of HLA 
class I heavy chains by flow cytometry using mAb A1.4. (A mean channels) 
Specific fluorescence obtained by subtracting background staining (no first 
mAb) from A1.4 staining. The number of the HPLC fractions is indicated 
at the bottom. The two bars at the right show A1.4 binding to cells in- 
cubated with medium alone for 7 h  at either 37 or 26~ 
of 132m-associated  mature HLA-E antigen on the cell surface 
might be peptide ligand associated. Individual peptide frac- 
tions were tested for the enhancement of HLA-E or HLA-B27 
cell surface expression  (Fig.  6).  Two fractions (23 and 24) 
significantly enhanced the HLA class I expression on the 
HLA-E transfectant clone. None of the fractions had an effect 
on the HLA-B27 transfectant (data  not shown). Adopting 
the same elution protocol, purified huB2m eluted from the 
reverse phase HPLC column in fraction 38. 
Discussion 
These findings suggest that the impaired expression of the 
HLA-E antigen may be the result of insufficient binding of 
peptide ligands (3, 7) or of complexing  longer peptides, giving 
rise to unstable molecules (27). Further experiments are needed 
to determine whether the extracted ligands were originally 
complexed with HLA-E.  Sequence analysis of the purified 
peptides  and  identification of the  self-protein  will  reveal 
whether the aberrant expression of the HLA-E molecule results 
from an insufficient pool of self-peptides capable of binding 
to HLA-E, or whether the structure of its binding cleft only 
accommodates peptides with  a rare  composition. Protein 
sequence  comparison  does  not  indicate  the  presence  of 
substitutions at positions known to be crucial  for ligand 
binding (28). 
In addition, HLA-E antigen expression may be affected by 
a reduced translation efficiency since the amount of HLA-E 
mRNA did not correlate with the HLA-E cell surface staining 
in transfectant clones.  The clones used in the experiments 
presented here  contained  similar  amounts  of steady-state 
hu/~2m and HLA class I mRNA, comparable with human 
tissues (M. Ulbrecht, manuscript submitted for publication). 
Regardless  of the reagent used for immunoprecipitation of 
pulse-labeled class I, the amount of HLA-E polypeptide was 
drastically reduced compared with the HLA-B27 immuno- 
precipitates.  The possibility of a rapid conversion of HLA-E 
into a non-hu132m-associated form that is not recognized by 
A1.4  cannot formally be excluded. 
It is unlikely that the poor cell surface expression of the 
HLA-E molecule is only due to its expression  in a mouse 
cell line. Class I antigen cell surface expression is easily de- 
tected upon transfection of HLA-A, -B, and -C genes (29, 
30) and no species-specific restriction in peptide binding and 
class I assembly has been described so far, although variability 
in MHC-encoded transporter or proteasome genes might affect 
the endoplasmic peptide spectrum (7, 31). Indeed, defective 
cell surface expression  of the HLA-E antigen was also ob- 
served upon transfection into human B-LCL 721.221 (16) cells. 
HLA-E might be representative  for a class of relative invar- 
iant class I antigens found in all species studied so far that 
share weak cell surface representation (16, 32, 33). 
Our results might suggest that the structure of HLA-E 
has evolved such that this class I antigen lost its function in 
presenting antigenic peptides to the immune system. This 
must not necessarily be true, since HLA-E, in its biochem- 
ical properties, behaves very similarly to H-2L  a, which serves 
as a restriction element for several virus-specific cytotoxic T 
cell responses in H-2  d mouse strains (34, 35). Moreover, the 
homologue of a nonpolymorphic HLA molecule, HLA-G, 
functions as major restriction element in a New World pri- 
mate species (36). 
A  specific physiological role for nonclassical MHC class 
I molecules is only emerging now. In the mouse, such mole- 
cules can present synthetic peptides to T cells, and it has been 
postulated that they display a greater specialization  of pep- 
tide binding than the classical MHC molecules (37-40). Sev- 
eral reports have suggested that TL region class I gene prod- 
ucts  might  be  involved in  antigen  presentation  to  y/8 
receptor-bearing T cells (38, 41). The influence of heat-shock 
proteins on Qa-1 cell surface expression (42), and the finding 
that several 3'//5 T  cell lines recognize heat-shock proteins 
(43),  have led to the hypothesis that the TL molecules and 
other nonclassical MHC class I molecules might, as a pri- 
mary line of defense, present peptides derived from an en- 
dogenous stress-response protein to "y/8 T cells (42).  In ad- 
dition, since they are not saturated with endogenous  peptides, 
they might preferentially  bind environmental antigens that 
can be recognized by the immune system. The observed stabili- 
zation of HLA-E class I antigens at reduced temperature might 
be of physiological significance in the skin, where the tem- 
perature is lower than elsewhere  in the body. 
It is also conceivable that HLA-E serves a more "ancient" 
function intracellularly as a "modulator" of endoplasmic pep- 
tide loading. This may be related  to the function of heat- 
shock proteins (hsp70),  in which the hypothetical structure 
of the peptide binding domain is similar to the MHC an- 
1088  Impaired Intracellular Transport and Cell Surface Expression  of HLA-E tigen binding site (44, 45).  Since HLA-E is retained and ac- 
cumulates in the class I "peptide-loading" compartment, the 
endoplasmic reticulum, it might influence the spectrum of 
peptides presented by classical class I molecules through low 
a~nity binding and easy release of peptides,  thus modulating 
the concentration of free peptides available. Finally, HLA-E 
might be involved in the postulated process  of trimming 
preprocessed peptides to the biologically active length of  eight 
to nine amino acids. 
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